Transporter‐Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target
- 12 January 2010
- journal article
- review article
- Published by Wiley in Molecular Informatics
- Vol. 29 (1-2), 16-26
- https://doi.org/10.1002/minf.200900075
Abstract
We examined the relationship between sedation and orthostatic hypotension, two central side effects and ABCB1 transporter‐mediated efflux for a set of 64 launched drugs that are documented as histamine H1 receptor antagonists. This relationship was placed in the context of passive diffusion (estimated using LogP, the octanol/water partition coefficient), receptor affinity, and the adjusted therapeutic daily dose, in order to account for side effect variability. Within this set, CNS permeability was not dependent on passive diffusion, as no significant differences were found for LogP and its pH‐corrected equivalent, LogD74. Sedation and orthostatic hypotension can be explained within the framework of ABCB1‐mediated efflux and adjusted dose, while target potency has less influence. ABCB1, an antitarget for anticancer agents, acts in fact as a drug target for nonsedating antihistamines. An empirical set of rules, based on the incidence of these two side effects, target affinity and dose was used to predict efflux effects for a number of drugs. Among them, azelastine and mizolastine are predicted to be effluxed via ABCB1‐mediated transport, whereas aripiprazole, clozapine, cyproheptadine, iloperidone, olanzapine, and ziprasidone are likely to be noneffluxed.Keywords
This publication has 48 references indexed in Scilit:
- The Drug Transporter−Metabolism Alliance: Uncovering and Defining the InterplayMolecular Pharmaceutics, 2009
- Transport at the Blood–Brain BarrierPublished by Wiley ,2009
- IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channelsNucleic Acids Research, 2008
- Computational Models for P‐Glycoprotein Substrates and InhibitorsPublished by Wiley ,2008
- In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous SystemDrug Metabolism and Disposition, 2007
- Histamine H 1 Blockers: From Relative Failures to Blockbusters within Series of AnaloguesPublished by Wiley ,2006
- Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and BrainJournal of Pharmacology and Experimental Therapeutics, 2005
- Role of respiratory infection in onset of asthma and chronic obstructive pulmonary diseaseClinical and Experimental Allergy, 1999
- The clinical impact of reported variance in potency of antipsychotic agentsActa Psychiatrica Scandinavica, 1995
- Hydrophobicity and Central Nervous System Agents: On the Principle of Minimal Hydrophobicity in Drug DesignJournal of Pharmaceutical Sciences, 1987